Verona Pharma PLC Holding(s) in Company (3710E)

TIDMVRP TIDMAV.

RNS Number : 3710E

Verona Pharma PLC

05 May 2017

 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 
-------------------------------------------------- 
 
 
 
 1. Identity of the issuer or the underlying            Verona Pharma plc 
  issuer 
  of existing shares to which voting rights 
  are 
  attached: (ii) 
-----------------------------------------------------  ------------------------------------------- 
 2 Reason for the notification (please tick the appropriate box or boxes): 
-------------------------------------------------------------------------------------------------- 
 An acquisition or disposal of voting rights 
---------------------------------------------------------------------------------------  --------- 
 An acquisition or disposal of qualifying financial instruments 
  which may result in the acquisition of shares already issued to 
  which voting rights are attached 
---------------------------------------------------------------------------------------  --------- 
 An acquisition or disposal of instruments with similar economic 
  effect to qualifying financial instruments 
---------------------------------------------------------------------------------------  --------- 
 An event changing the breakdown of voting rights 
---------------------------------------------------------------------------------------  --------- 
 Other (please       CHANGE TO THE TOTAL NUMBER OF VOTING RIGHTS IN 
  specify):           ISSUE 
------------------  -------------------------------------------------------------------  --------- 
 3. Full name of person(s) subject        Aviva plc & its subsidiaries 
  to the notification obligation: 
  (iii) 
---------------------------------------  --------------------------------------------------------- 
 4. Full name of shareholder(s)                Registered Holder: 
  (if different from 3.):(iv) 
                                                HSBC Global Custody Nominee (UK) Limited 
                                                501,275* 
 
                                                Chase (GA Group) Nominees Limited 1,292,033* 
 
                                                State Street Nominees Limited 63,903* 
 
                                                Available on request 2,482* 
 
                                                *denotes direct interest 
 
                                                Chase (GA Group) Nominees Limited 233,235 
 
                                                Chase Nominees Limited 62,166 
 
                                                Vidacos Nominees Limited 323,354 
---------------------------------------  --------------------------------------------------------- 
 5. Date of the transaction and           03 May 2017 
  date on 
  which the threshold is crossed 
  or 
  reached: (v) 
---------------------------------------  --------------------------------------------------------- 
 6. Date on which issuer notified:        04 May 2017 
---------------------------------------  --------------------------------------------------------- 
 7. Threshold(s) that is/are crossed      3% to <3% Change at Direct Interest Level 
  or                                       (Box 8A & Box 8A+8B) and >5% to <5% Change 
  reached: (vi, vii)                       at Combined Interest Level (Box 8A&8B) 
---------------------------------------  --------------------------------------------------------- 
 
 
 
 8. Notified details: 
---------------------------------------------------------------------------------------------------------------------- 
 A: Voting rights attached to shares (viii, ix) 
---------------------------------------------------------------------------------------------------------------------- 
 Class/type      Situation previous                Resulting situation after the triggering 
 of               to the triggering                 transaction 
 shares           transaction 
 
 if possible 
 using 
 the ISIN CODE 
--------------  --------------------------------  -------------------------------------------------------------------- 
                 Number            Number          Number       Number of voting              % of voting rights 
                  of                of              of shares    rights                        (x) 
                  Shares            Voting 
                                    Rights 
--------------  ----------------  --------------  -----------  ----------------------------  ------------------------- 
                                                   Direct       Direct           Indirect     Direct     Indirect 
                                                                 (xi)             (xii) 
--------------  ------  --------  -------  -----  -----------  ---------------  -----------  ---------  -------------- 
 Ordinary 
  Shares 
 
 
  GB00BYW2KH80   3,278,448*        3,278,448*      2,478,448    1,859,693        618,755      1.88%      0.62% 
                ----------------  --------------  -----------  ---------------  -----------  ---------  -------------- 
 
 * Includes Right to Recall Loaned Shares (800,000) 
---------------------------------------------------------------------------------------------------------------------- 
 B: Qualifying Financial Instruments 
---------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------------------------------------- 
 Type of financial       Expiration         Exercise/                 Number of voting             % of voting 
  instrument              date (xiii)        Conversion Period         rights that may              rights 
                                             (xiv)                     be 
                                                                       acquired if the 
                                                                       instrument is 
                                                                       exercised/ converted. 
----------------------  -----------------  ------------------------  ---------------------------  -------------------- 
                                                                      800,000* 
 RIGHT TO RECALL 
  LOANED SHARES          N/A                N/A                        *Direct Interest            0.81% 
----------------------  -----------------  ------------------------  ---------------------------  -------------------- 
 
 
 
 C: Financial Instruments with similar economic effect to Qualifying Financial 
  Instruments (xv, xvi) 
------------------------------------------------------------------------------------------------------ 
 Resulting situation after the triggering transaction 
------------------------------------------------------------------------------------------------------ 
 Type of financial   Exercise   Expiration     Exercise/     Number of voting     % of voting rights 
  instrument          price      date (xvii)    Conversion    rights instrument    (xix, xx) 
                                                period        refers to 
                                                (xviii) 
------------------  ---------  -------------  ------------  -------------------  --------------------- 
                                                                                  Nominal      Delta 
------------------  ---------  -------------  ------------  -------------------  -----------  -------- 
 
 
 
 Total (A+B+C) 
------------------------------------------------------ 
 Number of voting rights   Percentage of voting rights 
------------------------  ---------------------------- 
 3,278,448                 3.31% 
------------------------  ---------------------------- 
 
 
 9. Chain of controlled undertakings through which the voting rights and/or 
  the 
  financial instruments are effectively held, if applicable: (xxi) 
----------------------------------------------------------------------------- 
 The voting rights are managed and controlled by Aviva Investors Global 
  Services Limited and Friends Provident International Limited, with the 
  following chain of controlled undertakings:- 
 
  Aviva Investors Global Services Limited: 
   *    Aviva plc (Parent Company) 
 
 
   *    Aviva Group Holdings Limited (wholly owned subsidiary 
        of Aviva plc) 
 
 
   *    Aviva Investors Holdings Limited (wholly owned 
        subsidiary of Aviva Group Holdings Limited) 
 
 
   *    Aviva Investors Global Services Limited (wholly owned 
        subsidiary of Aviva Investors Holdings Limited) 
 
 
 
  Friends Provident International Limited: 
   *    Aviva plc (Parent Company) 
 
 
   *    Aviva Group Holdings Limited (wholly owned subsidiary 
        of Aviva plc) 
 
 
   *    Friends Provident International Limited (wholly owned 
        subsidiary of Aviva Group Holdings Limited) 
 
 Proxy Voting: 
----------------------------------------------------------------------------- 
 10. Name of the proxy holder:                               See Section 4 
----------------------------------------------------------  ----------------- 
 11. Number of voting rights proxy holder will 
  cease 
  to hold: 
----------------------------------------------------------  ----------------- 
 12. Date on which proxy holder will cease to 
  hold 
  voting rights: 
----------------------------------------------------------  ----------------- 
 
 
                                  Figures are based on a total number 
  13. Additional information:      of voting rights of 99,014,164, as 
                                   per the Company's Closing of Global 
                                   Offering and Total Voting Rights Announcement 
                                   of 02 May 2017. 
-------------------------------  ----------------------------------------------- 
 14. Contact name:                    Neil Whittaker, Aviva plc 

-------------------------------  ----------------------------------------------- 
 15. Contact telephone number:        01603 684420 
-------------------------------  ----------------------------------------------- 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLUGUUGAUPMGCA

(END) Dow Jones Newswires

May 05, 2017 10:32 ET (14:32 GMT)